1. Home
  2. COCP vs GV Comparison

COCP vs GV Comparison

Compare COCP & GV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COCP
    SELLHOLDBUYas of 20 hours ago
  • GV
    SELLHOLDBUYas of 20 hours ago
  • Stock Information
  • Founded
  • COCP N/A
  • GV 2013
  • Country
  • COCP United States
  • GV Canada
  • Employees
  • COCP N/A
  • GV N/A
  • Industry
  • COCP Biotechnology: Pharmaceutical Preparations
  • GV Other Consumer Services
  • Sector
  • COCP Health Care
  • GV Real Estate
  • Exchange
  • COCP Nasdaq
  • GV Nasdaq
  • Market Cap
  • COCP 15.3M
  • GV 12.3M
  • IPO Year
  • COCP N/A
  • GV 2022
  • Fundamental
  • Price
  • COCP $1.42
  • GV $2.49
  • Analyst Decision
  • COCP Strong Buy
  • GV
  • Analyst Count
  • COCP 1
  • GV 0
  • Target Price
  • COCP $7.00
  • GV N/A
  • AVG Volume (30 Days)
  • COCP 18.2K
  • GV 3.7M
  • Earning Date
  • COCP 03-31-2025
  • GV 04-15-2025
  • Dividend Yield
  • COCP N/A
  • GV N/A
  • EPS Growth
  • COCP N/A
  • GV N/A
  • EPS
  • COCP N/A
  • GV 0.32
  • Revenue
  • COCP N/A
  • GV $9,380,985.00
  • Revenue This Year
  • COCP N/A
  • GV N/A
  • Revenue Next Year
  • COCP N/A
  • GV N/A
  • P/E Ratio
  • COCP N/A
  • GV $8.75
  • Revenue Growth
  • COCP N/A
  • GV 11.25
  • 52 Week Low
  • COCP $1.35
  • GV $1.00
  • 52 Week High
  • COCP $3.26
  • GV $9.60
  • Technical
  • Relative Strength Index (RSI)
  • COCP 34.73
  • GV 38.22
  • Support Level
  • COCP $1.35
  • GV $3.00
  • Resistance Level
  • COCP $1.49
  • GV $3.38
  • Average True Range (ATR)
  • COCP 0.09
  • GV 0.53
  • MACD
  • COCP -0.00
  • GV -0.34
  • Stochastic Oscillator
  • COCP 23.33
  • GV 4.22

Stock Price Comparison Chart: COCP vs GV

COCP
GV
JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025April02468101214161820222426COCP VS GV

About COCP Cocrystal Pharma Inc.

Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first- and-in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).

About GV Visionary Education Technology Holdings Group Inc.

Visionary Holdings Inc is a private education providing company located in Canada, with subsidiaries in Canada and market partners in China, that offers high-quality education resources to students around the globe. The company aims to provide access to secondary, college, undergraduate and graduate, and vocational education to students in Canada through technological innovation so that more people can learn, grow, and succeed to their full potential. As a fully integrated provider of educational programs and services in Canada, the company has been serving and will continue to serve both Canadian and international students.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use